Turn Therapeutics TTRX
NASDAQ TTRX
$9.80 -0.27 (-2.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

Turn Therapeutics (TTRX) Notes Payables (2025 - 2026)

Turn Therapeutics (TTRX) posted quarterly Notes Payables of $2.8 million for Q1 2026, down 8.62% quarter-over-quarter from $3.0 million in Q4 2025.

Analysis

Turn Therapeutics (TTRX) Notes Payables (2025 - 2026) Analysis & Trends

Turn Therapeutics' Notes Payables history runs 2 years deep, the most recent figure standing at $2.8 million for Q1 2026.

  • In Q1 2026, Notes Payables changed N/A year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was $3.0 million, changed N/A from the prior year.
  • Notes Payables for Q1 2026 stood at $2.8 million, down from $3.0 million in the prior quarter.
  • The five-year high for Notes Payables was $3.0 million in Q4 2025, with the low at $2.8 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Turn Therapeutics 302.05 Mn 302.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.11 Mn
Mar 31, 2026 2.77 Mn
Dec 31, 2025 3.03 Mn